Also trades as: AVE.AX (ASX) · $vol 0M
AVEFF OTC
Avecho Biotechnology Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -10.0%
5Y: -10.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$1M
+0.0% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
$1M
+127.8% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+178.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$3M | -$2M | -$3M | $0 | -$4M |
| Depreciation & Amort. | $429K | $230K | $0 | $0 | $137K |
| Stock-Based Comp. | $558K | $203K | $0 | $0 | $0 |
| Change in Working Capital | -$691K | $242K | -$454K | $0 | $5M |
| Other Non-Cash Items | $580K | $677K | $813K | $0 | $458K |
| Operating Cash Flow | -$3M | -$2M | -$3M | $0 | $1M |
| — Investing Activities — | |||||
| Capital Expenditures | -$203K | -$53K | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $531 | $0 | $0 | -$16K | $0 |
| Investing Cash Flow | -$202K | -$53K | $0 | -$16K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $932K | -$1M |
| Stock Repurchased | -$294K | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$72K | -$80K | -$71K | -$77K | -$84K |
| Financing Cash Flow | $5M | -$78K | $7M | $855K | $1M |
| Net Change in Cash | $1M | -$2M | $4M | -$3M | $2M |
| Cash End of Period | $3M | $1M | $6M | $2M | $5M |
| Free Cash Flow | -$3M | -$2M | -$3M | -$4M | $1M |